品牌：源叶

产品编号：B20150 一键复制产品信息

CAS号：20874-52-6

分子式：C₄₂H₆₈O₁₃

分子量：780.98

MDL：MFCD09028095

别名：柴胡皂苷 D;Saikosaponin BII; Saikosaponin b2 std.; Saikosaponian D; SAIKOSAPONINB2STANDARD; SaikosaponinD; (3β,4α,16α)-13,28-Epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galact

货号	规格	价格	上海	北京	珠海	武汉	购买数量
B20150-20mg	分析标准品,HPLC≥98%	￥600.00 B20150-20mg ￥600.00 现货	21 10 >10	7	-	3
B20150-200mg	分析标准品,HPLC≥98%	￥2000.00 B20150-200mg ￥2000.00 现货	4 3 4	3	-	-

大包装询价收藏产品

加入购物车

产品介绍

SMILES：	CC1(C)CC[C@]2(CO3)[C@H](O)C[C@@]4(C)[C@]([C@]5([H])C=C[C@]43[C@]2([H])C1)(C)CC[C@@]([C@]5(C)CC6)([H])[C@@](CO)(C)[C@H]6O[C@@](O[C@H](C)[C@@H]7O)([H])[C@H](O)[C@H]7O[C@@]8([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8
熔点：	256- 259°C
沸点：	893.7°C at 760 mmHg
比旋光度：	(EtOH)+37
外观：	白色粉末
储存条件：	2-8℃
注意：	部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

参考文献(48篇)

48. [IF=2.6] Long Zhang et al."Integrating HPLC Fingerprinting, Gray Relational Analysis, and In Vitro–In Vivo Evaluation of Xiaochaihu Decoction and Its Nano-Phase."PHYTOCHEMICAL ANALYSIS.2026 Jan;: 47. [IF=5.7] Liu Kaixin et al."Fuzheng Jiedu formula attenuates acute pneumonia by coordinated regulation of macrophage NLRP3 inflammasome and neutrophil NETs."Chinese Medicine.2026 Dec;21(1):1 46. [IF=5.4] Kedian Chen et al."Honghua Xiaoyao Tablets Ameliorate Premenstrual Syndrome by Modulating HPA Axis and Restoring Ovarian Estrogen Synthesis to Attenuate Hippocampal Neuroinflammation."JOURNAL OF ETHNOPHARMACOLOGY.2025 Oct;:120688 45. [IF=4.8] Gu Xupeng et al."Genome-wide identification of BcMYB in Bupleurum Chinense DC. and its regulatory roles in saikosaponins synthesis under temperature stress."BMC PLANT BIOLOGY.2025 Dec;25(1):1577 44. [IF=5.4] Lihua Cui et al."Hu Gan Tang ameliorates metabolic-associated fatty liver disease by inhibiting ferroptosis through the Nrf2/GPX4 pathway."JOURNAL OF ETHNOPHARMACOLOGY.2025 Sep;353:120342

43. [IF=4.8] Li Fang et al."Insights into infraspecific differentiation of the medicinally important species Bupleurum Chinense revealed by morphological and molecular evidence."BMC PLANT BIOLOGY.2025 Dec;25(1):1-13 42. [IF=4.3] Zhang Wenli et al."Evaluation of different ecological regions for cultivation of best quality Bupleurum: a case study from Shanxi, China."BMC PLANT BIOLOGY.2025 Dec;25(1):1-14 41. [IF=14.7] Wenxiang Hong et al."Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis."Acta Pharmaceutica Sinica B.2025 Feb;: 40. [IF=4.1] Shengwei Zhou et al."Suitable concentrations of brassinolide application enhances growth performance and saikosaponin biosynthesis by transcriptional activation of triterpenoid pathway genes in Bupleurum chinense DC."Frontiers in Plant Science.2025 Mar;16 39. [IF=3.4] Guangjie Liu et al."Transcriptome analysis revealing the effect of Bupleurum scorzonerifolium Willd association with endophytic fungi CHS3 on the production of saikosaponin D."Heliyon.2024 Jun;10: 38. [IF=5.4] Ruolan Sun et al."Homotherapy-for-heteropathy of Bupleurum Chinense DC.-Scutellaria baicalensis Georgi in treating depression and colorectal cancer: A network pharmacology and animal model approach."JOURNAL OF ETHNOPHARMACOLOGY".2024 Mar;:118038 37. [IF=3.4] Tongtong Yang et al."Combination of histological and metabolomic assessments to evaluate the potential pharmacological efficacy of saikosaponin D."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS".2024 May;242:116001 36. [IF=5.4] Liangxin Zhao et al."UPLC-Q-Exactive/MS based analysis explore the correlation between components variations and anti-influenza virus effect of four quantified extracts of Chaihu Guizhi decoction."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117318 35. [IF=4.6] Zhenhuan Wang et al."Quantitative and Differential Analysis between Bupleurum chinense DC. and Bupleurum scorzonerifolium Willd. Using HPLC-MS and GC-MS Coupled with Multivariate Statistical Analysis."MOLECULES.2023 Jan;28(15):5630 34. [IF=2.838] Xu Manman et al."Kaixin Jieyu Granule attenuates neuroinflammation-induced depressive-like behavior through TLR4/PI3K/AKT/FOXO1 pathway: a study of network pharmacology and experimental validation."BMC Complementary Medicine and Therapies.2023 Dec;23(1):1 33. [IF=4.141] Yiqing Peng et al."Assessment of Genetic Diversity in Bupleurum spp. Basing Agronomic Traits, Medicinal Components and ISSR Markers."Genes.2023 Apr;14(4):951 32. [IF=6.656] Minna Huang et al."Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K/AKT/Nrf2 pathway."PHYTOMEDICINE.2023 Jun;114:154766 31. [IF=3.246] Guimei Liu et al."Saikosaponin D Inducing Apoptosis and Autophagy through the Activation of Endoplasmic Reticulum Stress in Glioblastoma."Biomed Research International.2022 Nov 24;2022:5489553 30. [IF=3.369] Li Liu et al."Effects of Trichoderma harzianum biofertilizer on growth, yield, and quality of Bupleurum chinense."Plant Direct.2022 Nov;6(11):e461 29. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199 28. [IF=4.927] Linlin Yang et al."Drought Stress Stimulates the Terpenoid Backbone and Triterpenoid Biosynthesis Pathway to Promote the Synthesis of Saikosaponin in Bupleurum chinense DC. Roots."MOLECULES.2022 Jan;27(17):5470 27. [IF=3.911] Du Jikun et al."Saikosaponin-D Mitigates Oxidation in SH-SY5Y Cells Stimulated by Glutamate Through Activation of Nrf2 Pathway: Involvement of PI3K."Neurotox Res. 2022 Jan;:1-11 26. [IF=2.45] Li Shengyun et al."Establishment and Application of a Method for the Determination of Ganoderic Acid A."J Food Quality. 2020;2020:6621853 25. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 24. [IF=3.205] Jie Tang et al."Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry."J Chromatogr B. 2021 Aug;1179:122827 23. [IF=3.337] Mengru Lai et al."Saikosaponin D Inhibits Proliferation and Promotes Apoptosis Through Activation of MKK4–JNK Signaling Pathway in Pancreatic Cancer Cells."Oncotargets Ther. 2020; 13: 9465–9479 22. [IF=3.375] Tian Gao et al."Use of Saikosaponin D and JNK inhibitor SP600125, alone or in combination, inhibits malignant properties of human osteosarcoma U2 cells."Am J Transl Res. 2019; 11(4): 2070–2080 21. [IF=4.36] Xiaojing Zhang et al."A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway."J Ethnopharmacol. 2022 Jan;283:114742 20. [IF=5.81] Cui Lihua et al."Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway."Front Pharmacol. 2021 Jun;0:1369 19. [IF=3.205] Min He et al."Simultaneous determination of multiple bioactive components of Bu-zhong-yi-qi-tang in rat tissues by LC–MS/MS: Application to a tissue distribution study."J Chromatogr B. 2017 Feb;1044-1045:177 18. [IF=3.396] Shi Weiwei et al."Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells."Mol Cell Biochem. 2018 Dec;449(1):219-226 17. [IF=4.396] Xiaoman Chen et al."Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells."Mol Pharmaceut. 2018;15(11):4974–4984 16. [IF=4.411] Dan-Dan Tian et al."Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats."Molecules. 2016 Jun;21(6):696 15. [IF=4.411] Wei Wang et al."In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism."Molecules. 2016 May;21(5):597 14. Wang, Wei, Dan-Dan Tian, and Zhang-Jin Zhang. "In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism." Molecules 21.5 (2016): 597.https://doi.org/10.3390/molecules21050597 13. Tian D-D, Wang W, Wang H-N, Sze SCW, Zhang Z-J. Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats. Molecules. 2016; 21(6):696. https://doi.org/10.3390/molecules 12. 敏,王猛猛,吴雨,陈文文,王之通,张磊阳,蒋健.补中益气汤6个成分在大鼠体内的药代动力学研究[J].辽宁中医杂志,2020,47(11):159-163. 11. 杨梦玲, 尤朋涛, 何丽珊,等. 基于UPLC-MS/MS分析胃溃疡模型大鼠口服加味小柴胡颗粒后血浆中8种有效成分的药代动力学[J]. 中国中药杂志, 2018, 43(18). 10. 赵昕彤, 辛国, 辛宇,等. 煎煮时间对柴胡中柴胡皂苷A和柴胡皂苷D含量的影响[J]. 人参研究, 2017. 9. 廖念, 庞雪, 周逸群,等. 正交试验法优选北柴胡麸炒工艺[J]. 中国药师, 2017, 020(004):738-740. 8. 曹雪, 蔡广知, 赵凌,等. 基于复合质量常数的北柴胡饮片等级评价[J]. 中国实验方剂学杂志, 2018(18). 7. 李英, 焦倩, 张天天,等. 基于地形因子的河北省北柴胡生态适宜性区划研究[J]. 中国中药杂志, 2017, 042(022):4402-4407. 6. 廖念庞雪周逸群等. 北柴胡麸煨工艺的正交试验法优选[J]. 时珍国医国药 2017(05):96-98. 5. 庞雪廖念周逸群等. 不同炮制方法对北柴胡中柴胡皂苷含量的影响[J]. 时珍国医国药 2016(12):2906-2908. 4. 宁艳梅杨秀娟陈晖张金保杨韬任远.不同比例鳖血炮制柴胡制品中柴胡总皂苷含量测定与比较[J].中兽医医药杂志 2019 38(05):9-13. 3. 辛国赵昕彤李文等. 不同时间煎煮柴胡对五柴胡饮中柴胡皂苷含量及药效学的影响[J]. 长春中医药大学学报 2018(4):641-644. 2. 张娜, 晏旎, 周蒙恩,等. 柴胡皂苷d对氧化应激诱导的人肝星状细胞活化后ROS形成及NLRP3炎性小体表达的影响[J]. 时珍国医国药, 2020(4):805-809. 1. 程玉鹏, 王洪月, 高宁,等. 柴胡与其内生真菌共培养的内生真菌中柴胡总皂苷含量测定[J]. 化学工程师, 2018, v.32;No.279(12):23-25.

质检证书(COA)

输入产品批号：

如何获取质检证书(COA)?

请输入货号和一个与之匹配的批号。
例如:
批号：JS298415 货号：S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

质量

浓度

体积

分子摩尔量

计算重置

柴胡皂苷D